These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21642282)

  • 1. Cardiac bone marrow cell therapy: the proof of the pudding remains in the eating.
    Janssens SP
    Eur Heart J; 2011 Jul; 32(14):1697-700. PubMed ID: 21642282
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
    Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and safety of intra-coronary bone marrow mononuclear cell transplantation in ST elevation myocardial infarction patients.
    Srimahachota S; Boonyaratavej S; Rerkpattanapipat P; Wangsupachart S; Tumkosit M; Bunworasate U; Nakorn TN; Intragumtornchai T; Kupatawinturn P; Pongam S; Saengsiri AO; Pothisri M; Sukseri Y; Bunprasert T; Suithichaiyakul T
    J Med Assoc Thai; 2009 Dec; 92(12):1591-6. PubMed ID: 20043559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study.
    Beitnes JO; Gjesdal O; Lunde K; Solheim S; Edvardsen T; Arnesen H; Forfang K; Aakhus S
    Eur J Echocardiogr; 2011 Feb; 12(2):98-106. PubMed ID: 20851818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial.
    van der Laan AM; Hirsch A; Haeck JD; Nijveldt R; Delewi R; Biemond BJ; Tijssen JG; Marques KM; Zijlstra F; van Rossum AC; Piek JJ
    JACC Cardiovasc Interv; 2011 Aug; 4(8):913-20. PubMed ID: 21851907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow mononuclear cell therapy for acute myocardial infarction: we know what we want, but we just don't know how yet.
    Wollert KC
    Heart; 2015 Mar; 101(5):337-8. PubMed ID: 25601817
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell therapy in myocardial infarction.
    Arnesen H; Lunde K; Aakhus S; Forfang K
    Lancet; 2007 Jun; 369(9580):2142-2143. PubMed ID: 17604783
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow tinctures for cardiovascular disease: lost in translation.
    Rehman J
    Circulation; 2013 May; 127(19):1935-7. PubMed ID: 23596005
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction.
    Yao K; Huang R; Sun A; Qian J; Liu X; Ge L; Zhang Y; Zhang S; Niu Y; Wang Q; Zou Y; Ge J
    Eur J Heart Fail; 2009 Jul; 11(7):691-8. PubMed ID: 19420003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of preconditioned bone marrow mononuclear cells by AT2R stimulation improves infarcted heart function via enhanced cardiac mobilization of implanted cells.
    Xu Y; Hu X; Wang L; Jiang Z; Liu X; Yu H; Zhang Z; Chen H; Chen H; Steinhoff G; Li J; Wang J
    Int J Cardiol; 2013 Oct; 168(4):4551-4. PubMed ID: 23870638
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
    Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cell treatment with PDGF-BB and reperfusion on cardiac persistence of mononuclear and mesenchymal bone marrow cells after transplantation into acute myocardial infarction in rats.
    Krausgrill B; Vantler M; Burst V; Raths M; Halbach M; Frank K; Schynkowski S; Schenk K; Hescheler J; Rosenkranz S; Müller-Ehmsen J
    Cell Transplant; 2009; 18(8):847-53. PubMed ID: 19520046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction.
    Villa A; Arnold R; Sánchez PL; Gimeno F; Ramos B; Cantero T; Fernández ME; Sanz R; Gutiérrez O; Mota P; García-Frade J; San Román JA; Fernández-Avilés F;
    Am J Cardiol; 2009 Jun; 103(12):1651-6. PubMed ID: 19539071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STIM-ulation for the big trial.
    Arranto CA
    Swiss Med Wkly; 2012; 142():w13633. PubMed ID: 22832910
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
    Simari RD; Pepine CJ; Traverse JH; Henry TD; Bolli R; Spoon DB; Yeh E; Hare JM; Schulman IH; Anderson RD; Lambert C; Sayre SL; Taylor DA; Ebert RF; Moyé LA
    Circ Res; 2014 May; 114(10):1564-8. PubMed ID: 24812350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transepicardial autologous transplantation of bone marrow mononuclear cells for acute myocardial infarction].
    Huang JS; Zheng SY; Mai MJ; Wu RB
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):849-51. PubMed ID: 18504218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results.
    Sürder D; Manka R; Moccetti T; Lo Cicero V; Emmert MY; Klersy C; Soncin S; Turchetto L; Radrizzani M; Zuber M; Windecker S; Moschovitis A; Bühler I; Kozerke S; Erne P; Lüscher TF; Corti R
    Circ Res; 2016 Jul; 119(3):481-90. PubMed ID: 27267068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques.
    Silva SA; Sousa AL; Haddad AF; Azevedo JC; Soares VE; Peixoto CM; Soares AJ; Issa AF; Felipe LR; Branco RV; Addad JA; Moreira RC; Tuche FA; Mesquita CT; Drumond CC; Junior AO; Rochitte CE; Luz JH; Rabischoffisky A; Nogueira FB; Vieira RB; Junior HS; Borojevic R; Dohmann HF
    Cell Transplant; 2009; 18(3):343-52. PubMed ID: 19558782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of using autologous mono-nuclears of the bone marrow in treatment of patients with ischemic heart disease].
    Sedov VM; Nemkov AS; Afanas'ev BV; Zverev OG; Nesterko AO; Fregatova LM; Belyĭ SA; Shloĭdo EA; Iudina OV; Ryzhkova DV; Zueva EE; Petrov NV; Stovpiuk OF; Tsurupa SP
    Vestn Khir Im I I Grek; 2006; 165(4):11-4. PubMed ID: 17120413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.